Southland Holdings, Inc. Form 8-K Summary
Business Context and Reporting Period
Southland Holdings, Inc. filed a Form 8-K dated September 19, 2023, under Item 7.01 to furnish an investor presentation for upcoming investor meetings in September 2023. The filing does not report a specific quarterly or annual financial period.
The company’s common stock and redeemable warrants trade on NYSE American under the symbols SLND and SLND WS, respectively. Southland identified itself as an emerging growth company.
Financial Metrics and Capitalization
The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, liquidity, backlog, or other operating metrics. It only references the investor presentation attached as Exhibit 99.1.
Material Changes Versus Prior Period
The filing does not disclose material changes versus a prior comparable period. No financial results, acquisitions, financing transactions, changes in outlook, or capital allocation actions are described in the provided text.
Guidance, Outlook, Risks, and Unusual Items
The company states that the attached investor presentation will be used in upcoming investor meetings. The presentation’s contents are not included in the provided filing text, so any guidance, outlook, management commentary, risk factors, contingencies, or unusual items cannot be evaluated.
The information in Item 7.01 and the attached exhibits is furnished and is not deemed filed for purposes of Section 18 of the Exchange Act, nor incorporated by reference into other filings except where expressly stated.
Key Facts for Investors to Verify
- Review Exhibit 99.1 for the investor presentation, including any financial metrics, operating targets, backlog data, and guidance.
- Verify whether the presentation contains non-GAAP measures and reconcile them to the company’s reported GAAP results.
- Check subsequent SEC filings for updates to guidance, liquidity, debt, project execution, and risk disclosures.
- Confirm the terms and potential dilution associated with the redeemable warrants, including the stated $11.50 per-share exercise price.